WATERTOWN, Mass., Aug. 09, 2016 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ:PSDV); (ASX:PVA), a leader in the development of sustained release drug delivery products primarily for eye diseases, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results